05 - Produits pharmaceutiques, vétérinaires et hygièniques
35 - Publicité; Affaires commerciales
Produits et services
Dietary foodstuffs for medical use; dietetic foodstuffs for
veterinary use; food supplements. Advertising; commercial business management; commercial
administration; dissemination of advertising material
(leaflets, prospectuses, printed matter, samples);
presentation of goods on all communication media for
retailing; document reproduction; computerized file
management service; website traffic optimization;
organization of exhibitions for commercial or advertising
purposes; online advertising on a computer network; rental
of advertising time on all communication media; publication
of advertising texts; rental of advertising space;
dissemination of advertisements; advice regarding
communication (advertising); public relations; advice
regarding communication (public relations).
2.
Aqueous liquid extract of Spirulina for the prevention and/or treatment of chemically induced peripheral neuropathy and their symptoms, composition and use thereof
A composition for use in the treatment and/or prevention of adverse side effects induced by an anti-cancer compound, said composition comprising an aqueous liquid extract, the aqueous liquid extract comprising Phycocyanin. The present invention also relates to the use of this aqueous liquid extract comprising Phycocyanin and optionally Spirulina polysaccharides, for the treatment and/or prevention of adverse side effects induced by an anti-cancer compound.
A composition for use in the treatment and/or prevention of adverse side effects induced by an anti-cancer compound, said composition comprising an aqueous liquid extract, the aqueous liquid extract comprising Phycocyanin. The present invention also relates to the use of this aqueous liquid extract comprising Phycocyanin and optionally Spirulina polysaccharides, for the treatment and/or prevention of adverse side effects induced by an anti-cancer compound.
Indeed, Phycocyanin, thanks to its antioxidant effects, can reduce the undesirable side effects induced by an anti-cancer compound.
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
35 - Publicité; Affaires commerciales
Produits et services
Laundry preparations; polishing preparations; degreasing
preparations; abrasive preparations; soaps; perfumes;
essential oils; cosmetics; lotions for hair; dentifrices;
depilatories; make-up removing products; lipstick; beauty
masks; shaving products; preservatives for leather
(polishes); creams for leather. Pharmaceutical products; veterinary products; sanitary
products for medicine; disinfectant soaps; medicinal soaps;
medicated shampoos; medicated dentifrices; dietetic foods
for medical use; dietetic foodstuffs for veterinary use;
food for babies; food supplements; articles for dressings;
teeth filling materials; dental impression materials;
antibacterial products for washing hands; bath preparations
for medical use; sanitary panties; sanitary towels; chemical
preparations for medical use; chemical preparations for
pharmaceutical use; medicinal herbs; medicinal herbal teas;
alloys of precious metals for dental use. Advertising; commercial business management; commercial
administration; office functions; dissemination of
advertising material (leaflets, prospectuses, printed
matter, samples); newspaper subscription services (for third
parties); arranging subscriptions to telecommunication
services for third parties; business management and
organization consultancy; accounting; photocopying services;
employment agency services; business management for
freelance service providers; computerized file management
service; traffic optimization for websites; organization of
exhibitions for commercial or advertising purposes; online
advertising on a computer network; rental of advertising
time on all communication media; publication of advertising
texts; rental of advertising space; dissemination of
advertisements; advice regarding communication
(advertising); public relations; advice regarding
communication (public relations); company audits (commercial
analyses); commercial intermediation services.
4.
Aqueous liquid extract of Spirulina for the prevention and/or treatment of chemically induced peripheral neuropathy and their symptoms, composition and use thereof
A composition for use in the treatment and/or prevention of adverse side effects induced by an anti-cancer compound, said composition comprising an aqueous liquid extract, the aqueous liquid extract comprising Phycocyanin. The present invention also relates to the use of this aqueous liquid extract comprising Phycocyanin and optionally Spirulina polysaccharides, for the treatment and/or prevention of adverse side effects induced by an anti-cancer compound.
A composition for use in the treatment and/or prevention of adverse side effects induced by an anti-cancer compound, said composition comprising an aqueous liquid extract, the aqueous liquid extract comprising Phycocyanin. The present invention also relates to the use of this aqueous liquid extract comprising Phycocyanin and optionally Spirulina polysaccharides, for the treatment and/or prevention of adverse side effects induced by an anti-cancer compound.
Indeed, Phycocyanin, thanks to its antioxidant effects, can reduce the undesirable side effects induced by an anti-cancer compound.
Composition for use in a method of protecting mammalian subjects against atherosclerosis development, in particular against atheroma formation or in atheroma reduction, by oral administration of an aqueous liquid extract of spirulina including phycocyanin. Said composition can be used in a method of protecting genetically hypercholestolemic mammalian subjects against atherosclerosis development. Moreover, said composition can be used especially for protecting offspring mammalian subjects against atherosclerosis development, by oral administration to mothers of the offspring subjects of said composition at least during a part of the gestation period of the offspring mother or at least during part of the gestation period and of the lactation period.
A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p. ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénale
AQUEOUS LIQUID EXTRACT OF SPIRULINA FOR THE PREVENTION AND/OR TREATMENT OF CHEMICALLY INDUCED PERIPHERAL NEUROPATHY AND THEIR SYMPTOMS, COMPOSITION AND USE THEREOF
Composition for use in treating and/or preventing the undesirable side effects caused by an anti-cancer compound, said composition comprising an aqueous liquid extract, the aqueous liquid extract comprising phycocyanin. The present invention also relates to the use of said aqueous liquid extract comprising phycocyanin, and optionally spirulina polysaccharides, for treating and/or preventing the undesirable side effects caused by an anti-cancer compound. Indeed, phycocyanin can be used, mainly due to its antioxidant effects, to reduce the undesirable side effects caused by an anti-cancer compound.
A61K 35/748 - Cyanobactéries, c.-à-d. bactéries bleu-vert ou algues bleu-vert, p. ex. spiruline
A61K 38/16 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés
A61P 25/02 - Médicaments pour le traitement des troubles du système nerveux des neuropathies périphériques
A61P 39/00 - Agents protecteurs généraux ou antipoisons
7.
AQUEOUS LIQUID EXTRACT OF SPIRULINA FOR PREVENTING AND/OR TREATING PERIPHERAL CHEMOTHERAPY-INDUCED NEUROPATHIES AND THE SYMPTOMS THEREOF, AND CORRESPONDING COMPOSITION AND USE
Composition for use in treating and/or preventing the undesirable side effects caused by an anti-cancer compound, said composition comprising an aqueous liquid extract, the aqueous liquid extract comprising phycocyanin. The present invention also relates to the use of said aqueous liquid extract comprising phycocyanin, and optionally spirulina polysaccharides, for treating and/or preventing the undesirable side effects caused by an anti-cancer compound. Indeed, phycocyanin can be used, mainly due to its antioxidant effects, to reduce the undesirable side effects caused by an anti-cancer compound.
A61K 38/16 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés
A61K 35/748 - Cyanobactéries, c.-à-d. bactéries bleu-vert ou algues bleu-vert, p. ex. spiruline
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire
A61P 13/12 - Médicaments pour le traitement des troubles du système urinaire des reins
A61P 25/02 - Médicaments pour le traitement des troubles du système nerveux des neuropathies périphériques
Composition comprising an aqueous liquid extract of phycobiliproteins, containing phycocyanin, which is obtained from cyanobacteria or micro-algae and which has not been subjected to any drying step, said composition being used to prevent or treat lipido-carbohydrate metabolism disorders in humans or mammals. In particular, the composition can be used to prevent or treat non-alcoholic hepatic steatosis or steatohepatitis.
A61K 35/748 - Cyanobactéries, c.-à-d. bactéries bleu-vert ou algues bleu-vert, p. ex. spiruline
C07K 14/195 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
A61P 3/00 - Médicaments pour le traitement des troubles du métabolisme
9.
METHOD FOR PREPARING A LIQUID EXTRACT OF PHYCOBILIPROTEINS, IN PARTICULAR PHYCOCYANIN, FROM CYANOBACTERIA OR MICROALGAE AND EXTRACT THUS OBTAINED
A method for preparing a liquid extract rich in phycocyanin from cyanobacteria or microalgae containing phycocyanin in solution, comprising a step of carrying out the cellular lysis of an aqueous suspension of said fresh cyanobacteria or microalgae, a step of macerating the lysate obtained, for several hours in a solution of divalent cations, while releasing the water-soluble molecules in the extracellular space, and one or more steps of clarifying and concentrating the suspension in order to isolate the water-soluble molecules, among them phycocyanin. This method is performed at a pH between 5 and 8.5, at room temperature, without drying. Of the phycocyanin of the original biomass, 99% is recovered. The aqueous extract obtained is stable over time and comprises a content of phycocyanin in non-denatured solution that may be greater than 0.5 g/L, having an antioxidant activity demonstrated in vivo.
The invention relates to a method for producing membrane polysaccharides from an organism selected from micro-organisms, unicellular organisms and filamentous fungi, said method comprising at least one step of extracting said membrane polysaccharides as well as a smaller-scale extraction of the soluble proteins, by mechanical treatment of said organism in a ball mill or by physical treatment of said organism by means of ultrasounds.
A61K 47/36 - PolysaccharidesLeurs dérivés, p. ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine
A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
11.
VISCOELASTIC MATERIAL PRODUCED BY HYDROTHERMAL LIQUEFACTION OF MICROALGAE
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
ONIRIS (France)
ECOLE DES MINES DE NANTES (France)
Inventeur(s)
Chailleux, Emmanuel
Audo, Mariane
Bujoli, Bruno
Queffelec, Clémence
Legrand, Jack
Paraschiv, Maria
Tazerout, Mohand
Lepine, Olivier
Abrégé
The invention relates to a viscoelastic material characterised in that it is produced by recovery of the hydrophobic phase obtained by a method of hydrothermal liquefaction from a biomass comprising at least one microalga and comprising at least 40 wt.% of water in relation to the total weight of the biomass, said hydrophobic phase comprising a viscoelastic oil and solid residues, wherein the quantity of solid residues amounts to between 15 wt.% and 30 wt.% of the total weight of the hydrophobic phase.
